Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.525 USD | -0.33% | -6.66% | +6.92% |
05-07 | Inozyme Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-08 | Transcript : Inozyme Pharma, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.92% | 281M | |
+26.52% | 44.96B | |
-0.79% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.46% | 26.08B | |
-21.48% | 19.03B | |
+6.09% | 12.75B | |
+27.77% | 12.06B | |
-3.40% | 11.75B |
- Stock Market
- Equities
- INZY Stock
- News Inozyme Pharma, Inc.
- Wedbush Adjusts Price Target for Inozyme Pharma to $23 From $25, Maintains Outperform Rating